Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00712
|
|||||
Drug Name |
Ampicillin
|
|||||
Synonyms |
6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid; AB-PC; AB-PCSol; ABPC; AMPICILLIN (SEE ALSO AMPICILLIN TRIHYDRATE 7177-48-2); AY 6108; AY-6108; Acillin; Adobacillin; Alpen; Ambidrin (TN); Amblosin; Amcill; Amfipen; Amfipen V; Aminobenzylpenicillin; Amipenix S; Ampen; Ampi-Co; Ampi-Tab; Ampi-bol; Ampichel; Ampicil; Ampicilina; Ampicilina [INN-Spanish]; Ampicillanyl; Ampicillin (USP/INN); Ampicillin A; Ampicillin Anhydrous; Ampicillin Base; Ampicillin [USAN:BAN:INN:JAN]; Ampicillin [USAN:INN:BAN:JAN];D-(-)-Ampicillin; Ampicillin acid; Ampicillin anhydrate; Ampicillina; Ampicillina [DCIT]; Ampicilline; Ampicilline [INN-French]; Ampicillinum; Ampicillinum [INN-Latin]; Ampicin; Ampifarm; Ampikel; Ampimed; Ampipenin; Ampipenin, nt3; Ampiscel; Ampisyn; Ampivax; Ampivet; Amplacilina; Amplin; Amplipenyl; Amplisom; Amplital; Ampy-Penyl; Anhydrous ampicillin; Anhydrous ampicillin (JP15); Austrapen; BA 7305; BRL 1341; BRL-1341; Bayer 5427; Binotal; Bonapicillin; Britacil; Campicillin; Cimex; Copharcilin; D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid; D-(-)-alpha-Aminobenzylpenicillin; D-(-)-alpha-Aminopenicillin; D-Ampicillin; D-Cillin; Delcillin; Deripen; Divercillin; Doktacillin; Duphacillin; Grampenil; Guicitrina; Guicitrine; HI 63; KS-R1; Lifeampil; Morepen; Norobrittin; Novo-ampicillin; Nuvapen; OMNIPEN (AMPICILLIN); Olin Kid; Omnipen; Omnipen (TN); Omnipen-N; Orbicilina; P 50; P-50; Pen A; Pen A Oral; Pen Ampil;Penbritin paediatric; Penbristol; Penbritin; Penbritin syrup; Penbritin-S; Penbrock; Penicillin, Aminobenzyl; Penicline; Penimic; Pensyn; Pentrex; Pentrexl; Pentrexyl; Pfizerpen A; Pfizerpen-A; Polycillin; Polycillin-N; Polyflex (Veterinary); Ponecil; Princillin; Principen; Principen 125; Principen 250; Principen 500; QIDamp; Racenacillin; Ro-Ampen; Rosampline;Roscillin; SK-Ampicillin; SQ 17382; Semicillin; Semicillin R; Servicillin; Sumipanto; Supen; Synpenin; Texcillin; Tokiocillin; Tolomol; Totacillin; Totacillin (sodium); Totacillin-N; Totalciclina; Totapen; Trifacilina; Ukapen; Ultrabion; Ultrabron; Vampen; Viccillin; Viccillin S; WY-5103; Wypicil
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Bacterial infections [ICD11:1A00-1H0Z] | Approved | [1] | |||
Therapeutic Class |
Antibiotics
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C16H19N3O4S
|
|||||
Canonical SMILES |
CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C
|
|||||
InChI |
InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1
|
|||||
InChIKey |
AVKUERGKIZMTKX-NJBDSQKTSA-N
|
|||||
CAS Number |
CAS 69-53-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 349.4 | Topological Polar Surface Area | 138 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
-1.1
|
|||||
PubChem CID | ||||||
PubChem SID |
11335641
,11360880
,11362844
,11365406
,11367968
,11371462
,11373737
,11376130
,11461852
,11466142
,11467262
,11484554
,11485803
,11488585
,11490117
,11491964
,11493864
,14802821
,14827659
,24891442
,26706523
,29215015
,29225245
,46392100
,46484751
,46505346
,47291088
,47440199
,47810705
,47885360
,47959687
,48035057
,48035058
,48184948
,48415562
,49698352
,49855717
,50064028
,50104132
,50930328
,53789146
,53801116
,56312591
,56314308
,612819
,7847272
,7978702
,8153929
,855874
,8803
|
|||||
ChEBI ID |
ChEBI:28971
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [3] | ||
PEPT2 | Transporter Info | Peptide transporter 2 | Substrate | [4] | ||
PEPT2 | Transporter Info | Peptide transporter 2 | Substrate | [4] | ||
References | ||||||
1 | Ampicillin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
3 | Several hPepT1-transported drugs are substrates of the Escherichia coli proton-coupled oligopeptide transporter YdgR. Res Microbiol. 2017 Jun;168(5):443-449. | |||||
4 | Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.